This article has Open Peer Review reports available.
The roots of Atractylodes japonica Koidzumi promote adipogenic differentiation via activation of the insulin signaling pathway in 3T3-L1 cells
© Han et al.; licensee BioMed Central Ltd. 2012
Received: 14 May 2012
Accepted: 12 September 2012
Published: 14 September 2012
Type 2 diabetes (T2D) is a complex metabolic disorder characterized by insulin resistance and hyperglycemia. Peroxisome proliferator-activated receptor gamma (PPARγ) is a key transcription factor and plays an important role in the regulation of genes involved in adipogenic differentiation, glucose metabolism and insulin signal transduction.
In this study, the effects of the root extract of Atractylodes japonica Koidzumi ( Atractylodis Rhizoma Alba, ARA) on the differentiation of 3T3-L1 preadipocytes and the possible mechanism of glucose transport were investigated. 3T3-L1 cells were cultured with insulin and ARA extract.
In 3T3-L1 cells, ARA extract significantly enhanced adipogenic differentiation and upregulated the expression of PPARγ genes and protein in a dose-dependent manner. ARA also promoted glucose transport by increasing the glucose transporter 4 (GLUT-4), phosphatidylinositol 3-kinase (PI3K) and insulin receptor substrates-1 (IRS-1) levels.
Our results suggest that ARA extract may be an attractive therapeutic agent for managing T2D via promoting the differentiation of adipocytes with the upregulation of PPARγ levels and the activation of the insulin signaling pathway.
The modern lifestyle, with its abundant nutrient supply and sedentary behavior, has resulted in dramatic increases in the rates of obesity-associated diseases including type 2 diabetes (T2D). T2D is a complex metabolic disorder characterized by insulin resistance and hyperglycemia. Insulin resistance is a major risk factor of T2D and refers to a state in which physiological concentrations of insulin are poorly effective. Insulin levels increase to compensate for progressing insulin resistance leading to decreased glucose uptake and glucose utilization. Therefore, insulin resistance in target tissues, including the adipose tissue, muscle and liver, is the central pathophysiological event in the development of T2D.
Adipocytes are key inducers of insulin resistance that modulate adipokine secretion in T2D. Abnormal differentiation of preadipocytes affects glucolipid metabolism and induces insulin resistance. Adipocyte differentiation is a complex process that involves expression of several adipocyte-specific genes, including PPARγ (peroxisome proliferator-activated receptor-gamma), which lead to morphological changes and lipid accumulation within the cells. PPARγ, which is mainly found in adipose tissue, is a key transcription factor that regulates adipogenesis and plays an important role in the regulation of genes involved in adipocyte differentiation, lipid storage, glucose metabolism and insulin signal transduction[6, 9]. PPARγ activation can increase the number of small adipocytes, which are more sensitive to insulin, and reduce the number of large adipocytes. In this regard, PPARγ has been an attractive target for new drug discovery, and several types of PPARγ agonists with new structures have been developed.
Insulin signaling involves a cascade of events initiated by insulin binding to its cell surface receptor, followed by receptor autophosphorylation and activation of receptor tyrosine kinases, resulting in tyrosine phosphorylation of insulin receptor substrates (IRS). IRS-1 is integrated with PI3-kinase (phosphatidylinositol 3-kinase), which is necessary but not sufficient for the stimulation of the glucose transporter (GLUT)-4-mediated increase in glucose transport. The final step in this signaling cascade is the translocation of GLUT4 from intracellular compartments to the plasma membrane, thereby facilitating the entry of glucose into insulin-sensitive cells like fat cells.
The root of Atractylodes japonica Koidzumi (Atractylodis Rhizoma Alba, ARA) is an herbal medicine traditionally used in East Asia for treatment of obesity and related complications. In recent years, several studies have reported that ARA has various pharmacological activities such as anti-obesity, anti-inflammatory, gastroprotective and anti-oxidant effects. However, the mechanism of its anti-diabetic effects has not yet been investigated.
Thus, in this study, to evaluate the potential anti-diabetic effects of ARA, 3T3-L1 preadipocytes were differentiated into adipocytes. The specific aim of this study was to verify the action mechanism underlying the beneficial effect of ARA on lipid accumulation, adipocytes differentiation and insulin signaling pathway, with focus on the extent of treatment during adipocytes differentiation.
Preparation of ARA extract
The roots of A. japonica Koidzumi (ARA) were purchased from the Kwanmyungdang Medicinal Herbs (Ulsan, South Korea) and authenticated by Prof. Yong-Ki Park, a medicinal botanist, as an author in this study. Voucher specimens (ARA-W-1201) have been deposited in the herbarium of Oriental Medicine R&D Center, Dongguk University, South Korea. The dried roots (210 g) were extracted by boiling in water for 3 h, filtered through a two-layer mesh and concentrated in a boiling water bath to obtain the residue (yields of 26%). ARA extract was stored at −20°C until the experiment was performed.
3T3-L1 cell culture and differentiation into adipocytes
3T3-L1 cells, murine preadipocytes (ATCC, Manassas, VA, USA) were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% heat-inactivated bovine calf serum (BCS; Hyclone, Logan, UT) in a 5% CO2 humidified atmosphere at 37°C. To differentiate preadipocytes into adipocytes, the cells were seeded in 60-mm dishes at a density of 1 × 106/mL cells, and then cultured to confluence for 8 days while changing the medium every 2 days, followed by culturing for 2 days in medium supplemented with 0.5 mM 3-isobutyl-1-methylxanthine (IBMX), 1 μM dexamethasone and 5 μg/mL insulin. The cells were cultured for an additional 1 day in medium containing 5 μg/mL insulin. ARA extract was dissolved in adipocyte-induction media and filtered through 0.2 μm-pore syringe filters. The cells were treated every 2 days with ARA extract at concentrations of 100, 250 and 500 μg/mL in adipocyte-induction media for 6 days.
Cell viability was assessed by the conversion of MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (MTT; Roche, Mannheim, Germany) to formazan. 3T3-L1 cells were pre-treated with ARA extract at different concentrations for 8 days. At the termination of culture, 10 μL of MTT solution was added to each well, and the cells were then cultured for 4 h. 100 μL of DMSO was added to each well, and then the optical density (OD) was measured at 550 nm by a microplate reader (GENios, TEKAN Instruments, Inc., Austria).
Oil Red O staining
3T3-L1 cells were washed with 1× phosphate-buffered saline (PBS) and fixed with 10% formalin-PBS solution for 1 h. After removing this solution, the differentiated cells were stained with Oil Red O dye (Sigma Aldrich, St. Louis, MO) for 30 min at room temperature. The cells were washed four times with distilled water. Images were collected using an Olympus microscope (Tokyo, Japan). Stained oil droplets were dissolved in isopropyl alcohol and quantified at 520 nm using a microplate reader (GENios, TEKAN Instruments, Inc., Austria).
Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA from the cells was isolated with TRIzol reagent (Invitrogen, Carlsbad, CA, USA). Total RNA was reverse transcribed for 1 h at 42°C in a reaction mixture containing RNA, 1× reverse transcriptase buffer (Promega, Madison, WI), 0.5 mM of dNTP (deoxynucleotide triphosphate), 3 mM MgCl2, 5 U RNase inhibitor (Amersham, Piscataway, NJ), 0.5 μM oligo-dT primer, and 5 U of Superscript Reverse Transcriptase (Promega, Madison, WI) in a total volume of 20 μL. The PCR was performed using the prepared cDNA as a template with the following cycle parameters: 94°C, 2 min, 30–35 cycles; 94°C, 30s; 56 ~ 59°C, 30s; 72°C, 1 min; 92°C, 10 min. PCR products were then resolved on 1% agarose gels at 100 V. Specific genes were verified by assessing their predicted sizes under UV light. The primer sequences for PPARγ and GAPDH were as follows: PPARγ [accession no. NM 011146] Fw: 5′-GAA AGA CAA CGG ACA AAT CAC C-3′ and Rv: 5′-GGG GGT GAT ATG TTT GAA CTT G-3′, and GAPDH [accession no. XM 994067.2] Fw: 5′-CTC CTG GAG TCT ACT GGT GT-3′ and Rv: 5′-GTC ATC ATA CTT GGC AGG TT-3′. GAPDH was used as an internal control for PCR.
The cells were lysed with lysis buffer containing10 mM Tris–HCl, pH 7.9, 10 mM NaCl, 3 mM MgCl2, and 1% NP-40. After centrifugation at 12,000 rpm for 10 min, the supernatant was stored at −80°C until use. The protein concentration was determined by Bradford’s assay. 30 μg/mL of protein were separated by 8% SDS-PAGE and then transferred to nitrocellulose membranes. The membranes were blocked with 5% skim milk (BD, Franklin Lakes, NJ, USA) in TBS-T buffer (10 mM Tris–HCl, 150 mM NaCl, and 0.5% Tween-20) for 1 h. The membranes were incubated overnight with primary antibodies at 4°C and then incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies. The blots were developed with ECL Western detection reagents (Amersham Bioscience, Piscataway, NJ). The antibodies used in this study were anti-PPARγ (1:1000, Santa Cruz Biotechnology, Santa Cruz, CA), anti-GLUT4 (1:500, Santa Cruz Biotechnology), anti-PI3K (1:1000, Cell Signaling Technology, Beverly, MA), anti-IRS-1 (1:500, Cell Signaling Technology), anti-phospho-IRS-1 (1:500, Cell Signaling Technology), anti-β-actin (1:1000, Sigma Aldrich) and HRP-labeled anti-rabbit or mouse IgG (1:5000; Santa Cruz Biotechnology).
The cells were grown on glass coverslips in 2-well culture plates. After 8-day treatment with ARA extract, the cells were fixed with 4% paraformaldehyde for 30 min, washed with PBS, and then permeabilized with 0.2% Triton X-100 in 1× PBS for 15 min at room temperature. After blocking in 1% BSA in 1× PBS for 1 h, the cells were incubated overnight with anti-GLUT-4 (1:50, Cell Santa Cruz Biotechnology) antibody at 4°C. Coverslips were washed and incubated with Alexa Fluor-conjugated goat anti-rabbit antibody (1:50, Santa Cruz Biotechnology) for 2 h at RT. After DAPI staining, the coverslips were mounted on glass slides and examined under a fluorescence microscope (Olympus, Japan).
Data of all experiments are expressed as the mean ± S.D. and are representative of three independent experiments. Statistical analysis was carried out by one-way ANOVA with the Post-Hoc test using Graphpad Prism 5.0 statistical analysis software (GraphPad Software, Inc., San Diego, CA). Values of p < 0.05 were considered significant.
Effect of ARA extract on cell viability
Effect of ARA extract on adipogenic differentiation
Effect of ARA extract on PPAR γ expression
Effect of ARA extract on GLUT4 expression
Effect of ARA extract on PI3K pathway
The present study provides the first evidence that the root extract of A. japonica (ARA) promotes the insulin-induced conversion of preadipocytes into adipocytes, accompanied by increased expression of PPARγ, a key adipogenic transcription factor, in 3T3-L1 cells. Moreover, we have demonstrated that ARA extract activated the insulin signaling pathway by increasing GLUT4 and PI3K/IRS-1 phosphorylation in adipocytes. Our results suggest that ARA extract may have inhibitory activity against T2D by promoting adipogenic differentiation with activation of the insulin signaling pathway.
As an index of adipogenic differentiation, lipid accumulation was measured using Oil Red O staining because lipid droplets produced in the adipocyte cytoplasm are selectively stained with Oil Red O. In this study, the effect of ARA extract on adipogenic differentiation was evaluated using Oil Red O staining. The result showed that treatment of ARA extract in 3T3-L1 preadipocytes remarkably promoted adipogenic differentiation. Furthermore, the enhanced rate of differentiation with ARA extract at 500 μg/mL was similar to that with troglitazone, a PPARγ activator. Troglitazone is a member of the drug class of TZDs (Thiazolidineodiones), which are a class of synthetic PPARγ ligands that improve insulin resistance in target tissues and are used for the treatment of T2D. PPARγ has emerged as a key regulator of adipogenic differentiation in adipose tissue. In mature adipocytes, PPARγ regulates insulin signaling, glucose and lipid metabolism. Therefore, PPARγ is a major target for the treatment of various diseases, including diabetes, and has been an attractive target for new drug discovery[13, 20]. This study showed that ARA extract effectively promoted adipogenic differentiation in preadipocytes by enhancing the PPARγ transcription levels. Based on the results of the present study, we suggest that the stimulatory effect of ARA extract on adipogenic differentiation may be mediated by up-regulation of PPARγ expression and activity.
PPARγ ligands are known to increase glucose transport by insulin-sensitive tissues by regulating the expression of several genes involved in glucose metabolism. Insulin responsiveness is acquired during the maturation and differentiation of adipocytes and involves the expression of proteins responsible for the phenotypic functions of adipocytes, such as GLUT4, PI3K and IRS-1. On the other hand, in insulin-resistant states, signal transduction via the insulin receptor is impaired and activation of downstream targets such as IRS-1 and GLUT4 is decreased. In this study, we demonstrated that ARA extract can increase the phosphorylation of IRS-1 and PI3K and the expression of GLUT4 in adipocytes, suggesting that ARA extract may improve insulin resistance.
In conclusion, our results showed that ARA extract significantly promoted adipogenic differentiation in 3T3-L1 preadipocytes with up-regulation of PPARγ expression via activation of the GLUT4/PI3K/IRS-1 insulin signaling pathways. Although the possibility that other mechanisms of ARA extract improve diabetic conditions should be studied, our findings suggest that ARA extract is an attractive therapeutic agent for managing T2D.
This study was supported by a grant from the Traditional Korean Medicine R&D Project, Ministry of Health & Welfare, Rep. of Korea (B090075, To. Y.-K. Park).
- Prentki M, Nolan CJ: Islet β cell failure in type 2 diabetes. J Clin Invest. 2006, 116: 1802-1812. 10.1172/JCI29103.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhou J, Zhou S: Berberine regulates peroxisome proliferator-activated receptors and positive transcription elongation factor b expression in diabetic adipocytes. Eur J Pharmacol. 2010, 649: 390-397. 10.1016/j.ejphar.2010.09.030.View ArticlePubMedGoogle Scholar
- Castan-Laurell I, Dray C, Knauf C, Kunduzova O, Valet P: Apelin, a promising target for type 2 diabetes treatment?. Trends Endocrinol Metab. 2012, 23: 234-241. 10.1016/j.tem.2012.02.005.View ArticlePubMedGoogle Scholar
- Burén J, Liu HX, Lauritz J, Eriksson JW: High glucose and insulin in combination cause insulin receptor substrate-1 and −2 depletion and protein kinase B desensitization in primary cultured rat adipocytes: possible implication for insulin resistance in type 2 diabetes. Eur J Endocrinol. 2003, 148: 157-167. 10.1530/eje.0.1480157.View ArticlePubMedGoogle Scholar
- Xue P, Hou Y, Zhang Q, Woods CG, Yarborough K, Liu H, Sun G, Anderson ME, Pi J: Prolonged inorganic arsenite exposure suppresses insulin-stimulated AKT S473 phosphorylation and glucose uptake in 3T3-L1 adipocytes: involvement of the adaptive antioxidant response. Biochem Biophys Res Commun. 2011, 407: 360-365. 10.1016/j.bbrc.2011.03.024.View ArticlePubMedPubMed CentralGoogle Scholar
- Ahn J, Lee H, Kim S, Ha T: Curcumin-induced suppression of adipogenic differentiation is accompanied by activation of Wnt/β-catenin signaling. Am J Physiol Cell Physiol. 2010, 298: 1510-1516. 10.1152/ajpcell.00369.2009.View ArticleGoogle Scholar
- Liu J, Lin H, Cheng P, Hu X, Lu H: Effects of ghrelin on the proliferation and differentiation of 3T3-L1 preadipocytes. J Huazhong Univ Sci Technol. 2009, 29: 227-230. 10.1007/s11596-009-0218-x.View ArticleGoogle Scholar
- Kim CK, Kim M, Oh SD, Lee SM, Sun B, Choi GS, Kim SK, Bae H, Kang C, Min BI: Effects of Atractylodes macrophala Koidzumi rhizome on 3T3-L1 adipogenesis and an animal model of obesity. J Ethnopharmacol. 2011, 137: 396-402. 10.1016/j.jep.2011.05.036.View ArticlePubMedGoogle Scholar
- Zhang WY, Lee JJ, Kim IS, Kim Y, Park JS, Myung CS: 7-O-Methylaromadendrin stimulates glucose uptake and improves insulin resistance in vitro. Biol Pharm Bull. 2010, 33: 1494-1499. 10.1248/bpb.33.1494.View ArticlePubMedGoogle Scholar
- Xu C, Wang LL, Liu HY, Zhou XB, Cao YL, Li S: C33H, a novel PPARα/γ dual agonist, has beneficial effects on insulin resistance and lipid metabolism. Acta Pharmacol Sin. 2006, 27: 223-228. 10.1111/j.1745-7254.2006.00263.x.View ArticlePubMedGoogle Scholar
- Choi K, Kim YB: Molecular mechanism of insulin resistance in obesity and type 2 diabetes. Korean J Intern Med. 2010, 25: 119-129. 10.3904/kjim.2010.25.2.119.View ArticlePubMedPubMed CentralGoogle Scholar
- Lee SH, Lee HJ, Lee YH, Lee BW, Cha BS, Kang ES, Ahn CW, Park JS, Kim HJ, Lee EY: Korean red ginseng (panax ginseng) improves insulin sensitivity in high fat fed Sprague–Dawley rats. Phytother Res. 2012, 26: 142-147. 10.1002/ptr.3610.View ArticlePubMedGoogle Scholar
- Kim D, Park KK, Lee SK, Lee SE, Hwang JK: Cornus kousa f. buerger ex miquel increases glucose uptake through activation of peroxisome proliferator-activated receptor gamma and insulin sensitization. J Ethnopharmacol. 2011, 133: 803-809. 10.1016/j.jep.2010.11.007.View ArticlePubMedGoogle Scholar
- Hong MH, Kim JH, Bae H, Lee NY, Shin YC, Kim SH, Ko SG: Atractylodes japonica koidzumi inhibits the production of proinflammatory cytokines through inhibition of the NF-kappaB/IkappaB signal pathway in HMC-1 human mast cells. Arch Pharm Res. 2010, 33: 843-851. 10.1007/s12272-010-0606-6.View ArticlePubMedGoogle Scholar
- Wang KT, Chen LG, Wu CH, Chang CC, Wang CC: Gastroprotective activity of atractylenolide III from Atractylodes ovate on ethanol-induced gastric ulcer in vitro and in vivo. J Pharm Pharmacol. 2010, 62: 381-388.View ArticlePubMedGoogle Scholar
- Wang KT, Chen LG, Chou DS, Liang WL, Wang CC: Anti-oxidative abilities of essential oils from Atractylodes ovate rhizome. Evid Based Complement Alternat Med. 2011, 10.1093/ecam/neq006.Google Scholar
- Lee OH, Lee HH, Kim JH, Lee BY: Effect of ginsenosides Rg3 and Re on glucose transport in mature 3T3-L1 adipocytes. Phytother Res. 2011, 25: 768-773.View ArticlePubMedGoogle Scholar
- Ikarashi N, Tajima M, Suzuki K, Toda T, Ito K, Ochiai W, Sugiyama K: Inhibition of preadipocyte differentiation and lipid accumulation by orengedokuto treatment of 3T3-L1 cultures. Phytother Res. 2012, 26: 91-100. 10.1002/ptr.3493.View ArticlePubMedGoogle Scholar
- Sharma AM, Staels B: Peroxisome proliferator-activated receptor gamma and adipose tissue-understanding obesity-related changes in regulation of lipid and glucose metabolism. J Clin Endocrinol Metab. 2007, 92: 386-395.View ArticlePubMedGoogle Scholar
- Yang Y, Shang W, Zhou L, Jiang B, Jin H, Chen M: Emodin with PPARγ ligand-binding activity promotes adipocyte differentiation and increases glucose uptake in 3T3-L1 cells. Biochem Biophys Res Commun. 2007, 353: 225-230. 10.1016/j.bbrc.2006.11.134.View ArticlePubMedGoogle Scholar
- Cho KW, Lee OH, Banz WJ, Moustaid-Moussa N, Shay NF, Kim YC: Daidzein and the daidzein metabolite, equol, enhance adipocyte differentiation and PPARgamma transcriptional activity. J Nutr Biochem. 2010, 21: 841-847. 10.1016/j.jnutbio.2009.06.012.View ArticlePubMedGoogle Scholar
- Oliver E, McGillicuddy F, Phillips C, Toomey S, Roche HM: The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA. Proc Nutr Soc. 2010, 69: 232-243. 10.1017/S0029665110000042.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/12/154/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.